Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v13-FR
Language English French
Date Updated 2019-10-11 2019-10-10
Drug Identification Number 02431130 02431130
Brand name VINORELBINE INJECTION, USP VINORELBINE INJECTION, USP
Common or Proper name Vinorelbine for Injection Vinorelbine for Injection
Company Name GENERIC MEDICAL PARTNERS INC GENERIC MEDICAL PARTNERS INC
Ingredients VINORELBINE VINORELBINE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 ml Vial. Each pack contains one vial. 5 ml Vial. Each pack contains one vial.
ATC code L01CA L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-07-01 2019-07-01
Actual start date 2019-07-01 2019-07-01
Estimated end date 2019-10-01 2019-10-01
Actual end date 2019-10-10 2019-10-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage over. GMP has removed, with effect 10 October, the 75% allocation on Vinorelbine 10 mg/ml 5 ml vials for all contracted accounts and direct off contract orders. Shortage over. GMP has removed, with effect 10 October, the 75% allocation on Vinorelbine 10 mg/ml 5 ml vials for all contracted accounts and direct off contract orders.
Health Canada comments